Circulating tumor cells as potential prognostic biomarkers for early-stage pancreatic cancer: A systematic review and meta-analysis

doi:10.5306/wjco.v14.i11.504

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1713)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

904

Figures (1-7)

136

Tables (1-2)

146

Sum=1248

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

104

Download

296

Sum=400

Nov 24, 2023 (publication date) through Jul 18, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Clin Oncol. Nov 24, 2023; 14(11): 504-517
Published online Nov 24, 2023. doi: 10.5306/wjco.v14.i11.504

Full Size Figure Download Figure

Figure 2 Forest plots of the five studies show a shorter overall survival and disease-free survival/progression-free survival/recurrence-free survival in early pancreatic patients with positive pre-treatment or post-treatment circulating tumor cells detection. A: Overall survival; B: Disease-free survival/progression-free survival/recurrence-free survival. CI: Confidence interval.

Citation: Zhang ZH, Bao YW, Zhao YJ, Wang JQ, Guo JT, Sun SY. Circulating tumor cells as potential prognostic biomarkers for early-stage pancreatic cancer: A systematic review and meta-analysis. World J Clin Oncol 2023; 14(11): 504-517
URL: https://www.wjgnet.com/2218-4333/full/v14/i11/504.htm
DOI: https://dx.doi.org/10.5306/wjco.v14.i11.504